Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.
A disulfide-stabilized beta-hairpin AMP with rapid, broad-spectrum microbicidal activity in research models.
Also known as: PG-1 · protegrin
Part of the Foundational & therapeutic peptides cluster
Overview
Protegrin-1 (PG-1) is an 18-residue arginine-rich antimicrobial peptide from porcine leukocytes. Two disulfide bonds lock it into an antiparallel beta-hairpin that forms membrane pores, giving rapid broad-spectrum activity in research. Its high activity against mammalian cells has limited systemic development; it remains a research peptide.
Source & context
Biological / chemical source: Porcine leukocytes (cathelicidin family)
Primary research or clinical context: Antimicrobial-peptide research (not an approved drug)
Beta-hairpin architecture
Unlike helical AMPs, protegrin-1 folds into a rigid beta-hairpin held by two cysteine disulfide bridges, with six cationic arginines. This scaffold enables fast membrane pore formation and is a favored template in AMP structure-activity research.
Research context and limits
In vitro, PG-1 is rapidly bactericidal against MRSA, Pseudomonas and other pathogens at low concentrations. However, notable hemolytic activity toward mammalian cells has driven design of safer analogs. This page is educational and describes research findings, not therapy.
Sequence
One-letter sequence commonly cited for Protegrin-1 (educational; isoforms and modifications may differ):
RGGRLCYCRRRFCVCVGR
Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.
Structure & chemistry
Molecular identity & reference confidence
Source-supported reference
Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.
- Molecular form
- Protegrin-1 (source record; form not independently established)
- Species
- Not established by this molecular identity audit
- Termini (N / C)
- Not specified / Not specified
Average reference mass
Reference policy updated: 2026-10-05
- PubChem molecular record · 2026-10-01
- Molecular formula
- C88H147N37O19S4
- Average reference mass
- ≈ 2,155.6
- PubChem CID: 16130513
- CAS RN: 168831-77-4
Chemistry values: PubChem · fetched 2026-10-01.
Protegrin-1 — reconstitution calculator
Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.
Reference form: Protegrin-1 (source record; form not independently established)Average reference mass: 2,155.6 Da
Enter an amount to see the volume it corresponds to.
Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.
FAQ about Protegrin-1
What is Protegrin-1?+
Protegrin-1 (PG-1) is an 18-residue arginine-rich antimicrobial peptide from porcine leukocytes. Two disulfide bonds lock it into an antiparallel beta-hairpin that forms membrane pores, giving rapid broad-spectrum activity in research. Its high activity against mammalian cells has limited systemic development; it remains a research peptide.
What Canadian product status is recorded for Protegrin-1?+
Canadian product status for Protegrin-1 has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.
What is the typical length of Protegrin-1?+
Protegrin-1 is commonly described as approximately 18 amino acids (Antimicrobial peptide).
Related peptides
References & further reading
- 1.Bolosov et al. (2023). Design of Protegrin-1 Analogs with Improved Antibacterial Selectivity. Pharmaceutics
- 2.Javed et al. (2024). Antimicrobial and immunomodulatory activities of porcine cathelicidin Protegrin-1. Mol Immunol
- 3.Rizzetto et al. (2025). Protegrin-1 and Analogues Against Acinetobacter baumannii: A Narrative Review. Pharmaceuticals (Basel)
- 4.Tang et al. (2023). Repurposing Antimicrobial Protegrin-1 as a Dual-Function Amyloid Inhibitor via Cross-seeding. ACS Chem Neurosci
- 5.Pan et al. (2021). Protegrin-1 Regulates Porcine Granulosa Cell Proliferation via the EGFR-ERK1/2/p38 Signaling Pathway in vitro. Front Physiol
- 6.Mohanram et al. (2014). Cysteine deleted protegrin-1 (CDP-1): anti-bacterial activity, outer-membrane disruption and selectivity. Biochim Biophys Acta
- 7.Hosseini Goki et al. (2024). Novel antimicrobial peptides based on Protegrin-1: In silico and in vitro assessments. Microb Pathog
- 8.Li et al. (2022). Protegrin-1 inhibits porcine ovarian granulosa cell apoptosis from H(2)O(2)-induced oxidative stress via the PERK/eIF2α/CHOP signaling pathway in vitro. Theriogenology
- 9.PMC — Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity
- 10.Wikipedia — Protegrin